K Kivistö1, P Nevalainen2, L Lauronen3, S Tupola1, E Pihko4, S Kivitie-Kallio1. 1. a Department of Social Pediatrics , Hospital for Children and Adolescents, Helsinki University Central Hospital and University of Helsinki , Helsinki , Finland . 2. b BioMag Laboratory , Hospital District of Helsinki and Uusimaa, HUS Medical Imaging Center, Helsinki University Central Hospital and University of Helsinki , Helsinki , Finland . 3. c Department of Clinical Neurophysiology , Hospital for Children and Adolescents and University of Helsinki , Helsinki , Finland , and. 4. d Brain Research Unit, O.V. Lounasmaa Laboratory , Aalto University School of Science , Espoo , Finland.
Abstract
OBJECTIVE: Opioid exposure during pregnancy is a potential risk factor for the developing central nervous system of the fetus. We studied evoked responses in buprenorphine-exposed newborns who displayed neonatal abstinence syndrome (NAS) to elucidate the possible alterations in functioning of the somatosensory and auditory systems. METHODS: We compared somatosensory (SEFs) and auditory evoked magnetic fields (AEFs), recorded with magnetoencephalography (MEG), of 11 prenatally buprenorphine-exposed newborns with those of 12 healthy newborns. Peak latencies, source strength and location of SEFs or AEFs were recorded. RESULTS: AEFs were present in all buprenorphine-exposed newborns without significant differences from those of healthy newborns. In contrast, though no group level differences in SEFs existed, at individual level the response deviated from the typical neonatal morphology in four buprenorphine-exposed newborns. CONCLUSIONS: Although buprenorphine exposure during pregnancy does not seem to cause constant deficiencies in somatosensory or auditory processing, in some newborns the typical development of somatosensory networks may be - at least transiently - disrupted.
OBJECTIVE: Opioid exposure during pregnancy is a potential risk factor for the developing central nervous system of the fetus. We studied evoked responses in buprenorphine-exposed newborns who displayed neonatal abstinence syndrome (NAS) to elucidate the possible alterations in functioning of the somatosensory and auditory systems. METHODS: We compared somatosensory (SEFs) and auditory evoked magnetic fields (AEFs), recorded with magnetoencephalography (MEG), of 11 prenatally buprenorphine-exposed newborns with those of 12 healthy newborns. Peak latencies, source strength and location of SEFs or AEFs were recorded. RESULTS: AEFs were present in all buprenorphine-exposed newborns without significant differences from those of healthy newborns. In contrast, though no group level differences in SEFs existed, at individual level the response deviated from the typical neonatal morphology in four buprenorphine-exposed newborns. CONCLUSIONS: Although buprenorphine exposure during pregnancy does not seem to cause constant deficiencies in somatosensory or auditory processing, in some newborns the typical development of somatosensory networks may be - at least transiently - disrupted.
Entities:
Keywords:
Auditory evoked magnetic field; buprenorphine; magnetoencephalography; neonatal abstinence syndrome; somatosensory evoked magnetic field
Authors: Yu-Han Chen; Joni Saby; Emily Kuschner; William Gaetz; J Christopher Edgar; Timothy P L Roberts Journal: Neuroimage Date: 2019-01-24 Impact factor: 6.556
Authors: Jason B Alipio; Adam T Brockett; Megan E Fox; Stephen S Tennyson; Coreylyn A deBettencourt; Dina El-Metwally; Nikolas A Francis; Patrick O Kanold; Mary Kay Lobo; Matthew R Roesch; Asaf Keller Journal: Addict Biol Date: 2020-03-18 Impact factor: 4.280